Batu Biologics Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Crowdfunding
  • Latest Deal Amount
  • $1.65M
Latest Deal Amount
  • Investors
  • 2

Batu Biologics General Information

Description

Developer of allogeneic cell therapies designed to create and break immune tolerance. The company's allogeneic cell therapies offers an allogeneic and universal donor cellular vaccine to stimulate a targeted immune response against the blood vessels of the tumor for an array of cancers, enabling patients to recover cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 9255 Towne Centre Drive
  • Suite 450
  • San Diego, CA 92121
  • United States
+1 (213) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Batu Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Equity Crowdfunding 25-Dec-2017 $1.65M 00.000 Completed Startup
3. Seed Round 19-Jun-2015 00.00 00.00 Completed Startup
2. Product Crowdfunding 17-Aug-2014 $100K Completed Startup
1. Accelerator/Incubator 01-Jan-2014 Completed Startup
To view Batu Biologics’s complete valuation and funding history, request access »

Batu Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of allogeneic cell therapies designed to create and break immune tolerance. The company's allogeneic cell ther
Biotechnology
San Diego, CA
7 As of 2017
00.000
000000000000 00.000

0000 000

iscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ven
0000 000000000
Geneva, Switzerland
000.00
0000 0000-00-00
000000&0 000.00

0000 000

re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000 000000000
South San Francisco, CA
000 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Batu Biologics Competitors (91)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amal Therapeutics Formerly VC-backed Geneva, Switzerland 000.00 000000&0 000.00
0000 000000 Venture Capital-Backed South San Francisco, CA 000 00000 00000000000 00000
0000000 0000000000 Corporation San Carlos, CA 000 00000 00000000 00000
0000000 Venture Capital-Backed Philadelphia, PA 00 00000 00000000000 00000
000000-000 0000000 Venture Capital-Backed Palo Alto, CA 00 00000 0000000000 00000
You’re viewing 5 of 91 competitors. Get the full list »

Batu Biologics Patents

Batu Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200297829-A1 Integrative immunotherapy for cancer treatment Pending 18-Mar-2019 000000000
US-20190282641-A1 Generation of tumor endothelium specific viruses Pending 16-Mar-2018 0000000000
US-20190255127-A1 Augmentation of oncolytic viral efficacy through immunological targeting tumor endothelial cells Abandoned 21-Feb-2018 000000000
US-20190239937-A1 Augmentation of abscopal effect of cryotherapy and other tumor cell death by anti-angiogenic and anti-tumor vaccination Pending 02-Feb-2018 000000000
US-20190224292-A1 Methods of augmenting tumor vaccine efficacy through endothelial targeting Pending 22-Jan-2018 A61K39/001102
To view Batu Biologics’s complete patent history, request access »

Batu Biologics Executive Team (4)

Name Title Board Seat Contact Info
Gerry Berg Chief Financial Officer
Thomas Ichim Ph.D Co-Founder, Co-Chief Scientific Officer and Board Member
You’re viewing 2 of 4 executive team members. Get the full list »

Batu Biologics Board Members (7)

Name Representing Role Since
Hong Ma Ph.D Batu Biologics Board Member & Vice President, Business Development 000 0000
Joe Peck Jr. Self Board Member 000 0000
John Chiplin Ph.D Self Board Member 000 0000
Thomas Ichim Ph.D Self Co-Founder, Co-Chief Scientific Officer and Board Member 000 0000
Vladimir Bogin MD Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Batu Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Batu Biologics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Joe Peck Angel (individual) Minority 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator 000 0000 000000 0
To view Batu Biologics’s complete investors history, request access »